Gilles Darcis

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression

Gilles Darcis, Anna Kula, Sophie Bouchat et al. · PLoS Pathogens · 2015 · 279 citations · Full text

Latency-reversing Agent Combinations, Immunology, Hiv-1 Eradication +22

The Current Status of Latency Reversing Agents for HIV-1 Remission

Anthony Rodari, Gilles Darcis, Carine Van Lint · Annual Review of Virology · 2021 · 107 citations · Full text

Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates <scp>HIV</scp> ‐1

Sophie Bouchat, Nadège Delacourt, Anna Kula et al. · EMBO Molecular Medicine · 2015 · 84 citations · Full text

Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study

Gilles Darcis, Antoine Bouquegneau, Nathalie Maes et al. · International Journal of Infectious Diseases · 2021 · 61 citations · Full text

Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, Belgium

Christelle Meuris, Cécile Kremer, Anton Geerinck et al. · JAMA Network Open · 2021 · 56 citations · Full text